Researchers identify the Asah1 gene as a promising target for novel therapies to treat nonalcoholic fatty liver disease ...
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Non-alcoholic fatty liver disease has no early signs. Is your liver at risk? Expert reveals these simple tests could save your life!
Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...
Otherwise, it would lead to diseases like acute (sudden) hepatitis (inflammation), chronic (long duration) hepatitis, fatty ...
When mothers eat a diet high in fat and sugars, their unborn babies can develop liver stress that continues into early life.
A lower prevalence is seen in people with rural backgrounds. In an interview with HT Lifestyle, Dr Rajesh Battina, Consultant - Gastroenterology at Manipal Hospital in Vijayawada, shared, “In ...
A fatty liver is the most common. Dr Sudeep Khanna, senior consultant, gastroenterology, Indraprastha Apollo Hospitals, ...
Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results